Dey Indranil has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $25K.

Dey Indranil (name may also appear as Indranil Dey) is an executive whose SEC filing context identifies him as the President and Chief Executive Officer of Bluejay Diagnostics, Inc. as of the most recent filing date provided (May 18, 2026). Public biographical details beyond the SEC context are not included in the provided information.
| Role | President and CEO, Director |
|---|---|
| Notability | 45/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-18 | BJDX | Bluejay Diagnostics, Inc. | P — Open-market purchase | 12.5K | $2.00 | $25K |
Dey Indranil (name may also appear as Indranil Dey) is an executive whose SEC filing context identifies him as the President and Chief Executive Officer of Bluejay Diagnostics, Inc. as of the most recent filing date provided (May 18, 2026). Public biographical details beyond the SEC context are not included in the provided information.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchases ($25K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Dey Indranil profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.